Xtant Medical Holdings, INC Form 4 insider transactions

Xtant Medical Holdings, Inc. CFO Scott C Neils disposed of 8,084 common shares to cover tax withholding obligations related to restricted stock unit vesting.

Xtant Medical Holdings director John K. Bakewell filed an amended Form 4 to correct his beneficial ownership, disclosing a new deferred stock unit award.

Xtant Medical Holdings Director Stavros G. Vizirgianakis acquired 553,797 shares of common stock through a deferred stock unit award.

Xtant Medical Holdings Director Jonn R. Beeson acquired 158,228 deferred stock units, increasing his beneficial ownership.

Xtant Medical Holdings, Inc. Director John K. Bakewell was granted 158,228 deferred stock units, vesting in November 2026.

Xtant Medical Holdings, Inc. director Abhinav Jain received a deferred stock unit award of 158,228 shares, vesting in November 2026.

Xtant Medical Holdings, Inc. director Tyler Lipschultz received a deferred stock unit award of 158,228 shares, vesting in November 2026.

Xtant Medical CEO Sean Browne received 394,937 DSUs and up to 789,874 PSUs tied to a three-year stock performance period, with vesting through 2029.

COO Mark A. Schallenberger received 292,253 DSUs and up to 584,506 PSUs on November 15, 2025, bringing reported beneficial ownership to 670,866 shares.

Xtant Medical Holdings, Inc. CFO Scott C. Neils was granted 263,291 deferred stock units and up to 526,582 performance stock units, aligning his incentives with long-term shareholder value.

Xtant Medical Holdings, Inc. CEO Sean E. Browne reported the withholding of 10,605 common shares for tax obligations related to restricted stock unit vesting.

Xtant Medical Holdings, Inc. CFO Scott C. Neils reported the withholding of 34,131 shares to cover tax obligations upon the vesting of restricted stock units.

OrbiMed Advisors LLC and related entities report the sale of common stock in Xtant Medical Holdings, Inc., resulting in adjustments to their beneficial ownership.

An amended SEC filing reveals an adjustment to the number of shares issuable to Xtant Medical Holdings' Chief Operations Officer, Mark A. Schallenberger, under deferred stock unit awards.

Scott C. Neils, CFO of Xtant Medical Holdings, sold shares to cover tax withholding obligations upon the vesting of restricted stock units.

Sean E. Browne, President and CEO of Xtant Medical Holdings, reports disposition of shares to cover tax obligations.

Director Stavros G. Vizirgianakis reports acquisition of deferred stock units in Xtant Medical Holdings, Inc. under the 2023 Equity Incentive Plan.

Lori D. Mitchell-Keller, a director of Xtant Medical Holdings, reported the acquisition of 162,162 shares and the disposal of an unquantified amount of common stock on August 15, 2024.

Director Robert McNamara acquired 162,162 shares of Xtant Medical Holdings through a deferred stock unit award, subject to continued service as a director.

Director Jonn R. Beeson reports acquisition of deferred stock units and adjustments to his holdings in Xtant Medical Holdings, Inc.

Director John K Bakewell reports acquisition of deferred stock units and holdings in Xtant Medical Holdings, Inc.

Kevin D. Brandt, Chief Commercial Officer of Xtant Medical Holdings, reports a transaction involving the withholding of shares to cover tax obligations upon vesting of restricted stock units.

Chief Financial Officer of Xtant Medical Holdings, Inc., Neils Scott C, reports the withholding of shares to cover tax obligations upon vesting of restricted stock units.

Sean E. Browne, President and CEO of Xtant Medical Holdings, reports disposition of shares to cover tax obligations upon vesting of restricted stock units.

Chief Commercial Officer Kevin Brandt reports acquiring shares through a restricted stock unit award and disposing of shares, resulting in a total beneficial ownership of 1,000,069 shares.

Sean E. Browne, President and CEO of Xtant Medical Holdings, reports the acquisition of restricted stock units under the company's equity incentive plans.

Mark A. Schallenberger, Chief Operations Officer of Xtant Medical Holdings, reports acquisition of restricted stock units and total holdings.

Xtant Medical Holdings' CFO, Scott C. Neils, received a deferred stock unit award on April 3, 2024, which will vest over the next four years, conditioned upon continued employment.